RadteraRadtera
‹ All protocols
‹ Back to all protocols

FDG PET/CT (Oncology, Whole Body)

PET+ ContrastWhole Body
Indications
  • Staging/restaging of most solid malignancies and lymphoma
  • Treatment response assessment
  • Detection of recurrence; characterization of indeterminate lesions
  • Radiation therapy planning
  • Cancer of unknown primary
Patient prep
  • Fast at least 4-6 hours (water only); no caloric intake during uptake
  • Check blood glucose: should be <200 mg/dL (optimal <140-150); reschedule or manage if high
  • Avoid strenuous exercise 24 h (muscle uptake)
  • Keep patient warm and resting/quiet during uptake (reduce brown fat/muscle uptake)
  • Diabetics: schedule appropriately, hold short-acting insulin per protocol
  • Verify pregnancy/breastfeeding status
Contrast
AgentF-18 FDG (fluorodeoxyglucose)
RouteIV
Dose10-15 mCi (370-555 MBq); weight-based ~2.5-5.0 MBq/kg
TimingUptake 60 min (acceptable range 55-75 min); consistency critical for SUV
Technique
  • Integrated PET/CT, skull base to mid-thigh (eyes-to-thighs); add limbs for melanoma/sarcoma
  • Low-dose CT for attenuation correction and localization (+/- diagnostic CT with IV/oral contrast)
  • Arms up if possible to reduce artifact; void before scan (urinary excretion)
  • ~2-4 min per bed position
Series / Sequences
#Series / SequencePlaneNotes
1Whole-body PETAxial/multiplanarSkull base to mid-thigh; SUV quantification
2CT (low-dose or diagnostic)AxialAttenuation correction + anatomic localization
Key points
  • Strict glucose control and consistent ~60-min uptake essential for reliable SUV
  • Keep patient warm/still to minimize brown fat and muscle uptake
  • Physiologic uptake: brain, myocardium (variable), liver, GU tract, bowel, lymphoid tissue
  • Hyperglycemia/recent insulin shifts FDG to muscle and lowers tumor conspicuity
  • Inflammation/infection and post-treatment changes can cause false positives
References
• Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure Guideline for Tumor Imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47(5):885–895. link
• Boellaard R, Delgado-Bolton R, Oyen WJG, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328–354. doi:10.1007/s00259-014-2961-x
• ACR-ACNM-SNMMI-SPR Practice Parameter for Performing FDG-PET/CT in Oncology. Revised 2021 (Resolution 20). link
• Radiopaedia: PET-CT indications link
Source: Researched — verify against your institution
Reference template — verify and adapt to your scanner, vendor and institution before clinical use. Not a substitute for clinical judgment.